U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 677

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr11:100219331-134910140
GRCh38:
Chr11:100348599-135040246
AASDHPPT, ABCG4, ACAD8, ACAT1, ACRV1, ADAMTS15, ADAMTS8, ALG9, ALKBH8, ANGPTL5, ANKK1, APLP2, APOA1, APOA1-AS, APOA4, APOA5, APOC3, ARCN1, ARHGAP20, ARHGAP32, ARHGAP42, ARHGAP42-AS1, ARHGEF12, ATM, ATP5MG, B3GAT1, B3GAT1-DT, BACE1, BACE1-AS, BARX2, BCL9L, BCO2, BIRC2, BIRC3, BLID, BSX, BTG4, BUD13, C11orf52, C11orf65, C11orf71, C11orf87, C1QTNF5, C2CD2L, CADM1, CADM1-AS1, CARD16, CARD17, CARD18, CASP1, CASP12, CASP4, CASP5, CBL, CCDC15, CCDC153, CD3D, CD3E, CD3G, CDON, CENATAC, CENATAC-DT, CEP126, CEP164, CFAP300, CFAP68, CHEK1, CLDN25, CLMP, CNTN5, COLCA1, CRTAM, CRYAB, CUL5, CWF19L2, CXCR5, DCPS, DCUN1D5, DDI1, DDX10, DDX25, DDX6, DIXDC1, DLAT, DPAGT1, DRD2, DSCAML1, DYNC2H1, EI24, ELMOD1, ESAM, ESAM-AS1, ETS1, ETS1-AS1, EXPH5, FAM118B, FDX1, FDXACB1, FEZ1, FLI1, FOXR1, FOXRED1, FRA11B, FXYD2, FXYD6, FXYD6-AS1, FXYD6-FXYD2, GLB1L2, GLB1L3, GRAMD1B, GRIA4, GRIK4, GSEC, GUCY1A2, H2AX, HEPACAM, HEPN1, HINFP, HMBS, HOATZ, HSPA8, HSPB2, HSPB2-C11orf52, HTR3A, HTR3B, HYLS1, HYOU1, IFT46, IGSF9B, IL10RA, IL18, JAM3, JAML, JHY, KBTBD3, KCNJ1, KCNJ5, KCNJ5-AS1, KIRREL3, KIRREL3-AS1, KIRREL3-AS2, KIRREL3-AS3, KMT2A, LAYN, LINC00900, LINC01395, LINC02098, LINC02151, LINC02550, LINC02551, LINC02552, LINC02697, LINC02702, LINC02703, LINC02706, LINC02712, LINC02714, LINC02715, LINC02719, LINC02725, LINC02727, LINC02730, LINC02731, LINC02732, LINC02743, LINC02744, LINC02762, LINC02763, LINC02764, LINC02873, LOC100131626, LOC100132078, LOC100132686, LOC100507548, LOC100652768, LOC101928535, LOC101928847, LOC101928940, LOC101928985, LOC101929208, LOC101929227, LOC101929427, LOC101929473, LOC101929538, LOC101929653, LOC102723838, LOC105369509, LOC105369532, LOC105369535, LOC105369558, LOC106865368, LOC107984399, LOC108165612, LOC108165613, LOC108281156, LOC108353823, LOC108491825, LOC110120853, LOC110120944, LOC110121342, LOC110121415, LOC110121418, LOC110121460, LOC111365219, LOC111413012, LOC111429625, LOC111464985, LOC111465015, LOC111718489, LOC111982889, LOC111982891, LOC111982892, LOC111982893, LOC111982894, LOC112042777, LOC112042778, LOC112042779, LOC112042780, LOC112042783, LOC112042784, LOC112042785, LOC112042786, LOC112061819, LOC112061820, LOC112061821, LOC112061822, LOC112061823, LOC112067710, LOC112067711, LOC113939918, LOC113939919, LOC114803469, LOC116225302, LOC116225303, LOC116225304, LOC116225305, LOC116225306, LOC116225307, LOC118567325, LOC121392936, LOC121392937, LOC121392938, LOC121392939, LOC121392940, LOC121392941, LOC121392942, LOC121392943, LOC121392944, LOC121392945, LOC121392946, LOC121392947, LOC121392948, LOC121392949, LOC121392950, LOC121392951, LOC121392952, LOC121392953, LOC121392954, LOC121832819, LOC121832820, LOC121832821, LOC121832822, LOC121832823, LOC121832824, LOC124625825, LOC124625826, LOC124625827, LOC124625828, LOC124625830, LOC124625831, LOC124625832, LOC124625833, LOC124625834, LOC124625835, LOC124625836, LOC124625837, LOC124625838, LOC124625839, LOC124625840, LOC124625841, LOC124625842, LOC124625843, LOC124625844, LOC124625847, LOC124625848, LOC124625849, LOC124625850, LOC124625851, LOC124625852, LOC124625853, LOC124625854, LOC124625855, LOC124625856, LOC124625857, LOC124625858, LOC124625859, LOC124625860, LOC124625861, LOC124625862, LOC124625863, LOC124625864, LOC124625865, LOC124625866, LOC124625867, LOC124625868, LOC124625870, LOC124625871, LOC124625872, LOC124625873, LOC124625874, LOC124625875, LOC126861312, LOC126861313, LOC126861314, LOC126861315, LOC126861316, LOC126861317, LOC126861318, LOC126861319, LOC126861320, LOC126861321, LOC126861322, LOC126861323, LOC126861324, LOC126861325, LOC126861326, LOC126861327, LOC126861328, LOC126861329, LOC126861330, LOC126861331, LOC126861332, LOC126861333, LOC126861334, LOC126861335, LOC126861336, LOC126861337, LOC126861338, LOC126861339, LOC126861340, LOC126861341, LOC126861342, LOC126861343, LOC126861344, LOC126861345, LOC126861346, LOC126861347, LOC126861348, LOC126861349, LOC126861350, LOC126861351, LOC126861352, LOC126861353, LOC126861354, LOC126861355, LOC126861356, LOC126861357, LOC126861358, LOC126861359, LOC126861360, LOC126861361, LOC126861362, LOC126861363, LOC126861364, LOC126861365, LOC126861366, LOC126861367, LOC126861368, LOC126861369, LOC126861370, LOC126861371, LOC126861372, LOC126861373, LOC126861374, LOC126861375, LOC126861376, LOC126861377, LOC126861378, LOC126861379, LOC126861380, LOC126861381, LOC126861382, LOC126861383, LOC126861384, LOC126861385, LOC126861386, LOC126861387, LOC126861388, LOC126861389, LOC126861390, LOC126861391, LOC126861392, LOC126861393, LOC126861394, LOC126861395, LOC126861396, LOC126861397, LOC126861398, LOC126861399, LOC126861400, LOC126861401, LOC126861402, LOC126861403, LOC126861404, LOC126861405, LOC126861406, LOC126861407, LOC126861408, LOC126861409, LOC127823033, LOC128462392, LOC128462393, LOC128462394, LOC128462411, LOC128772354, LOC128772355, LOC128772356, LOC128772357, LOC128772358, LOC128772359, LOC128772360, LOC128772361, LOC128772362, LOC128772363, LOC128772364, LOC128772365, LOC128772366, LOC128772367, LOC128772368, LOC128772369, LOC128772370, LOC128772371, LOC128772372, LOC128772373, LOC399975, LOC403312, LOC649133, MCAM, MFRP, MIR100, MIR100HG, MIR10526, MIR125B1, MIR3167, MIR34B, MIR34BHG, MIR34C, MIR3920, MIR4301, MIR4491, MIR4492, MIR4493, MIR4693, MIR4697, MIR6090, MIR6716, MIR6756, MIR8052, MIRLET7A2, MMP1, MMP10, MMP12, MMP13, MMP20, MMP20-AS1, MMP27, MMP3, MMP7, MMP8, MPZL2, MPZL3, MSANTD2, MSANTD2-AS1, MSANTD4, NCAM1, NCAM1-AS1, NCAPD3, NECTIN1, NECTIN1-AS1, NECTIN1-DT, NFRKB, NHERF4, NKAPD1, NLRX1, NNMT, NPAT, NRGN, NTM, NTM-AS1, NTM-IT, NXPE1, NXPE2, NXPE4, OAF, OPCML, OPCML-IT1, OR10D3, OR10G4, OR10G6, OR10G7, OR10G8, OR10G9, OR10S1, OR4D5, OR6M1, OR6T1, OR6X1, OR8A1, OR8B12, OR8B2, OR8B3, OR8B4, OR8B8, OR8D1, OR8D2, OR8D4, OR8G1, OR8G3P, OR8G5, PAFAH1B2, PANX3, PATE1, PATE2, PATE3, PATE4, PCSK7, PDGFD, PGR, PGR-AS1, PHLDB1, PIH1D2, PKNOX2, PKNOX2-AS1, PKNOX2-DT, PLET1, POGLUT3, POU2AF1, POU2AF2, POU2AF3, POU2F3, PPP2R1B, PRDM10, PRDM10-DT, PTS, PUS3, RAB39A, RBM7, RDX, REXO2, RNF214, RNF26, ROBO3, ROBO4, RPS25, RPUSD4, SC5D, SCN2B, SCN3B, SCN4B, SDHD, SENCR, SIAE, SIDT2, SIK2, SIK3, SLC35F2, SLC37A2, SLC37A4, SLN, SMIM35, SNORD13I, SNORD14C, SNORD14D, SNORD14E, SNORD150, SNORD153, SNX19, SORL1, SORL1-AS1, SPA17, SPATA19, SRPRA, ST14, ST3GAL4, STT3A, STT3A-AS1, TAGLN, TBCEL, TBCEL-TECTA, TBRG1, TECTA, TEX12, THY1, THYN1, TIMM8B, TIRAP, TIRAP-AS1, TLCD5, TMEM123, TMEM123-DT, TMEM133, TMEM218, TMEM225, TMEM25, TMEM45B, TMPRSS13, TMPRSS4, TMPRSS5, TP53AIP1, TRAPPC4, TREH, TRIM29, TRK-TTT2-1, TRPC6, TTC12, TTC12-DT, TTC36, TTC36-AS1, UBASH3B, UBE4A, UPK2, USP2, USP2-AS1, USP28, VPS11, VPS26B, VSIG10L2, VSIG2, VWA5A, YAP1, ZBTB16, ZBTB44, ZBTB44-DT, ZC3H12C, ZNF202, ZPR1, ZW10
See casesPathogenic
(Aug 12, 2011)
criteria provided, single submitter
2.
GRCh37:
Chr11:111530104-112126455
GRCh38:
Chr11:111659380-112255732
See casesUncertain significance
(Aug 27, 2010)
no assertion criteria provided
3.
GRCh37:
Chr11:111957548-111966525
GRCh38:
Chr11:112086824-112095801
LOC126861339, SDHDPheochromocytoma, Paragangliomas 1Pathogenic
(Jun 1, 2016)
criteria provided, single submitter
4.
GRCh37:
Chr11:111957622-111965704
GRCh38:
Chr11:112086898-112094980
LOC126861339, SDHDCowden syndrome 3, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Pheochromocytoma, Cowden syndrome 3, Paragangliomas 1,
Carney-Stratakis syndrome, Pheochromocytoma
Pathogenic
(Apr 14, 2021)
criteria provided, single submitter
5.
GRCh37:
Chr11:111957622-111965704
GRCh38:
Chr11:112086898-112094980
LOC126861339, SDHDCowden syndrome 3, Paragangliomas 1, Carney-Stratakis syndrome,
Pheochromocytoma
Uncertain significance
(Jun 12, 2018)
criteria provided, single submitter
6.
GRCh37:
Chr11:111957628
GRCh38:
Chr11:112086904
LOC126861339, SDHDnot providedUncertain significance
(Dec 21, 2020)
criteria provided, single submitter
7.
GRCh37:
Chr11:111957628
GRCh38:
Chr11:112086904
LOC126861339, SDHDHereditary cancer-predisposing syndromeUncertain significance
(Feb 22, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr11:111957628
GRCh38:
Chr11:112086904
LOC126861339, SDHDHereditary cancer-predisposing syndrome, not providedUncertain significance
(Jun 3, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr11:111957632
GRCh38:
Chr11:112086908
LOC126861339, SDHDM1LParagangliomas with sensorineural hearing loss, Pheochromocytoma, Carney-Stratakis syndrome,
Cowden syndrome 3, Hereditary cancer-predisposing syndrome, not provided
Pathogenic
(Jan 7, 2022)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr11:111957632
GRCh38:
Chr11:112086908
LOC126861339, SDHDM1VParagangliomas with sensorineural hearing loss, Cowden syndrome 3, Pheochromocytoma,
Carney-Stratakis syndrome
Pathogenic
(Feb 17, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr11:111957634
GRCh38:
Chr11:112086910
LOC126861339, SDHDM1ICarney-Stratakis syndrome, Cowden syndrome 3, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss, Hereditary cancer-predisposing syndrome
Pathogenic
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr11:111957634
GRCh38:
Chr11:112086910
LOC126861339, SDHDM1IParagangliomas with sensorineural hearing loss, Cowden syndrome 3, Pheochromocytoma,
Carney-Stratakis syndrome, Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma-paraganglioma
Pathogenic
(Mar 31, 2022)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr11:111957635
GRCh38:
Chr11:112086911
LOC126861339, SDHDA2TCowden syndrome 3, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Pheochromocytoma
Uncertain significance
(Aug 30, 2021)
criteria provided, single submitter
14.
GRCh37:
Chr11:111957636
GRCh38:
Chr11:112086912
LOC126861339, SDHDA2VHereditary cancer-predisposing syndrome, Carney-Stratakis syndrome, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss, Cowden syndrome 3
Uncertain significance
(Dec 21, 2022)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr11:111957636
GRCh38:
Chr11:112086912
LOC126861339, SDHDA2GCarney-Stratakis syndrome, Cowden syndrome 3, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Uncertain significance
(Aug 21, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr11:111957637
GRCh38:
Chr11:112086913
LOC126861339, SDHDHereditary cancer-predisposing syndromeLikely benign
(Apr 7, 2020)
criteria provided, single submitter
17.
GRCh37:
Chr11:111957637
GRCh38:
Chr11:112086913
LOC126861339, SDHDPheochromocytoma, Cowden syndrome 3, Carney-Stratakis syndrome,
Paragangliomas with sensorineural hearing loss
Likely benign
(Aug 27, 2018)
criteria provided, single submitter
18.
GRCh37:
Chr11:111957638
GRCh38:
Chr11:112086914
LOC126861339, SDHDV3LPheochromocytoma, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3
Uncertain significance
(Sep 24, 2021)
criteria provided, single submitter
19.
GRCh37:
Chr11:111957638
GRCh38:
Chr11:112086914
LOC126861339, SDHDV3ICarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Cowden syndrome 3,
Pheochromocytoma
Uncertain significance
(Apr 22, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr11:111957638
GRCh38:
Chr11:112086914
LOC126861339, SDHDV3FCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Pheochromocytoma,
Cowden syndrome 3
Uncertain significance
(Sep 1, 2021)
criteria provided, single submitter
21.
GRCh37:
Chr11:111957640-111957641
GRCh38:
Chr11:112086916-112086917
LOC126861339, SDHDW5fsnot providedLikely pathogenic
(Mar 1, 2017)
criteria provided, single submitter
22.
GRCh37:
Chr11:111957640
GRCh38:
Chr11:112086916
LOC126861339, SDHDCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Pheochromocytoma,
Cowden syndrome 3
Likely benign
(Mar 13, 2017)
criteria provided, single submitter
23.
GRCh37:
Chr11:111957640-111957641
GRCh38:
Chr11:112086916-112086917
LOC126861339, SDHDL4fsCowden syndrome 3, Pheochromocytoma, Paragangliomas with sensorineural hearing loss,
Carney-Stratakis syndrome, Pheochromocytoma, Carney-Stratakis syndrome,
Paragangliomas 1
Pathogenic
(Jan 1, 2016)
criteria provided, single submitter
24.
GRCh37:
Chr11:111957641
GRCh38:
Chr11:112086917
LOC126861339, SDHDL4VHereditary cancer-predisposing syndromeLikely benign
(Mar 28, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr11:111957641
GRCh38:
Chr11:112086917
LOC126861339, SDHDL4FHereditary cancer-predisposing syndrome, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3, Pheochromocytoma
Uncertain significance
(Mar 6, 2023)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr11:111957643
GRCh38:
Chr11:112086919
LOC126861339, SDHDCowden syndrome 3, Carney-Stratakis syndrome, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Likely benign
(Sep 26, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr11:111957644
GRCh38:
Chr11:112086920
LOC126861339, SDHDW5Rnot provided, Hereditary cancer-predisposing syndromeUncertain significance
(Jul 7, 2022)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr11:111957644-111957645
GRCh38:
Chr11:112086920-112086921
LOC126861339, SDHDW5fsParagangliomas with sensorineural hearing loss, Carney-Stratakis syndrome, Cowden syndrome 3,
Pheochromocytoma, not provided
Pathogenic
(Oct 16, 2019)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr11:111957644
GRCh38:
Chr11:112086920
LOC126861339, SDHDW5RHereditary cancer-predisposing syndrome, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3, Pheochromocytoma
Uncertain significance
(Sep 1, 2021)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr11:111957645
GRCh38:
Chr11:112086921
LOC126861339, SDHDW5*Cowden syndrome 3, Paragangliomas with sensorineural hearing loss, Pheochromocytoma,
Carney-Stratakis syndrome
Pathogenic
(Oct 2, 2021)
criteria provided, single submitter
31.
GRCh37:
Chr11:111957646
GRCh38:
Chr11:112086922
LOC126861339, SDHDW5*Pheochromocytoma, Cowden syndrome 3, Carney-Stratakis syndrome,
Paragangliomas with sensorineural hearing loss
Pathogenic
(Jan 17, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr11:111957647
GRCh38:
Chr11:112086923
LOC126861339, SDHDR6GCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Pheochromocytoma,
Cowden syndrome 3
Uncertain significance
(Oct 13, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr11:111957648
GRCh38:
Chr11:112086924
LOC126861339, SDHDR6KPheochromocytoma, Carney-Stratakis syndrome, Cowden syndrome 3,
Paragangliomas with sensorineural hearing loss, Hereditary cancer-predisposing syndrome
Uncertain significance
(Apr 14, 2023)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr11:111957648-111957651
GRCh38:
Chr11:112086924-112086927
LOC126861339, SDHDL7fsCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Pheochromocytoma,
Cowden syndrome 3, Paragangliomas 1
Pathogenic/Likely pathogenic
(Jan 23, 2020)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr11:111957649
GRCh38:
Chr11:112086925
LOC126861339, SDHDR6SCarney-Stratakis syndrome, Cowden syndrome 3, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Uncertain significance
(Sep 20, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr11:111957649
GRCh38:
Chr11:112086925
LOC126861339, SDHDCowden syndrome 3, Pheochromocytoma, Paragangliomas with sensorineural hearing loss,
Carney-Stratakis syndrome, Hereditary cancer-predisposing syndrome, not provided,
not specified
Likely benign
(Oct 25, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr11:111957650
GRCh38:
Chr11:112086926
LOC126861339, SDHDCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Pheochromocytoma,
Cowden syndrome 3, Hereditary cancer-predisposing syndrome
Likely benign
(Jul 22, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr11:111957651
GRCh38:
Chr11:112086927
LOC126861339, SDHDL7PPheochromocytoma, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3
Uncertain significance
(Sep 1, 2021)
criteria provided, single submitter
39.
GRCh37:
Chr11:111957651
GRCh38:
Chr11:112086927
LOC126861339, SDHDL7QPheochromocytoma, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3
Uncertain significance
(Aug 27, 2021)
criteria provided, single submitter
40.
GRCh37:
Chr11:111957651
GRCh38:
Chr11:112086927
LOC126861339, SDHDL7RPheochromocytoma, Carney-Stratakis syndrome, Cowden syndrome 3,
Paragangliomas with sensorineural hearing loss
Uncertain significance
(Aug 28, 2021)
criteria provided, single submitter
41.
GRCh37:
Chr11:111957652
GRCh38:
Chr11:112086928
LOC126861339, SDHDCarney-Stratakis syndrome, Cowden syndrome 3, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Likely benign
(Apr 29, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr11:111957652
GRCh38:
Chr11:112086928
LOC126861339, SDHDHereditary cancer-predisposing syndromeLikely benign
(Jul 12, 2021)
criteria provided, single submitter
43.
GRCh37:
Chr11:111957652
GRCh38:
Chr11:112086928
LOC126861339, SDHDCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Pheochromocytoma,
Cowden syndrome 3, Hereditary cancer-predisposing syndrome
Likely benign
(Sep 14, 2022)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr11:111957653
GRCh38:
Chr11:112086929
LOC126861339, SDHDS8GCarney-Stratakis syndrome, Pheochromocytoma, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3
Uncertain significance
(Aug 24, 2021)
criteria provided, single submitter
45.
GRCh37:
Chr11:111957654
GRCh38:
Chr11:112086930
LOC126861339, SDHDS8NPheochromocytoma, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3, Hereditary cancer-predisposing syndrome
Uncertain significance
(May 27, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr11:111957656
GRCh38:
Chr11:112086932
LOC126861339, SDHDA9TCowden syndrome 3, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Pheochromocytoma
Uncertain significance
(Sep 23, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr11:111957656
GRCh38:
Chr11:112086932
LOC126861339, SDHDA9SCowden syndrome 3, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Pheochromocytoma
Uncertain significance
(Aug 27, 2021)
criteria provided, single submitter
48.
GRCh37:
Chr11:111957657
GRCh38:
Chr11:112086933
LOC126861339, SDHDA9VCarney-Stratakis syndrome, Pheochromocytoma, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3, Hereditary cancer-predisposing syndrome
Uncertain significance
(Oct 5, 2021)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr11:111957657
GRCh38:
Chr11:112086933
LOC126861339, SDHDA9GCowden syndrome 3, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Pheochromocytoma
Uncertain significance
(Oct 18, 2021)
criteria provided, single submitter
50.
GRCh37:
Chr11:111957658
GRCh38:
Chr11:112086934
LOC126861339, SDHDPheochromocytoma, Cowden syndrome 3, Paragangliomas with sensorineural hearing loss,
Carney-Stratakis syndrome, Hereditary cancer-predisposing syndrome
Likely benign
(Oct 12, 2022)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr11:111957658
GRCh38:
Chr11:112086934
LOC126861339, SDHDCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Pheochromocytoma,
Cowden syndrome 3
Likely benign
(Oct 13, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr11:111957659
GRCh38:
Chr11:112086935
LOC126861339, SDHDV10IHereditary cancer-predisposing syndrome, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Pheochromocytoma, Cowden syndrome 3
Uncertain significance
(Feb 26, 2022)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr11:111957664
GRCh38:
Chr11:112086940
LOC126861339, SDHDPheochromocytoma, Cowden syndrome 3, Paragangliomas with sensorineural hearing loss,
Carney-Stratakis syndrome
Likely benign
(Sep 30, 2021)
criteria provided, single submitter
54.
GRCh37:
Chr11:111957664
GRCh38:
Chr11:112086940
LOC126861339, SDHDC11*Paragangliomas with sensorineural hearing loss, Cowden syndrome 3, Pheochromocytoma,
Carney-Stratakis syndrome, Hereditary cancer-predisposing syndrome, Paragangliomas 1,
Pheochromocytoma
Pathogenic
(Oct 10, 2022)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr11:111957665
GRCh38:
Chr11:112086941
LOC126861339, SDHDG12RCarney-Stratakis syndrome, Cowden syndrome 3, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Uncertain significance
(Feb 9, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr11:111957665
GRCh38:
Chr11:112086941
LOC126861339, SDHDG12SMitochondrial complex 2 deficiency, nuclear type 3, Paragangliomas with sensorineural hearing loss, Cowden syndrome 3,
Pheochromocytoma, Carney-Stratakis syndrome, Hereditary cancer-predisposing syndrome,
not provided, not specified, Paragangliomas 1,
Carney-Stratakis syndrome, Pheochromocytoma ...see more
Conflicting interpretations of pathogenicity
(Aug 15, 2023)
criteria provided, conflicting interpretations
57.
GRCh37:
Chr11:111957666
GRCh38:
Chr11:112086942
LOC126861339, SDHDG12VCowden syndrome 3, Carney-Stratakis syndrome, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Uncertain significance
(Oct 24, 2021)
criteria provided, single submitter
58.
GRCh37:
Chr11:111957666
GRCh38:
Chr11:112086942
LOC126861339, SDHDG12DCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Pheochromocytoma,
Cowden syndrome 3
Uncertain significance
(Aug 18, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr11:111957667
GRCh38:
Chr11:112086943
LOC126861339, SDHDCowden syndrome 3, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Pheochromocytoma
Likely benign
(Apr 30, 2018)
criteria provided, single submitter
60.
GRCh37:
Chr11:111957668
GRCh38:
Chr11:112086944
LOC126861339, SDHDA13SCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Pheochromocytoma,
Cowden syndrome 3, Hereditary cancer-predisposing syndrome
Uncertain significance
(Jul 18, 2022)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr11:111957668
GRCh38:
Chr11:112086944
LOC126861339, SDHDA13TCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Pheochromocytoma,
Cowden syndrome 3
Uncertain significance
(Oct 13, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr11:111957669
GRCh38:
Chr11:112086945
LOC126861339, SDHDA13GCarney-Stratakis syndrome, Pheochromocytoma, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3
Uncertain significance
(Aug 31, 2021)
criteria provided, single submitter
63.
GRCh37:
Chr11:111957669
GRCh38:
Chr11:112086945
LOC126861339, SDHDA13VHereditary cancer-predisposing syndrome, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Pheochromocytoma, Cowden syndrome 3
Uncertain significance
(May 24, 2022)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr11:111957670
GRCh38:
Chr11:112086946
LOC126861339, SDHDPheochromocytoma, Paragangliomas with sensorineural hearing loss, Cowden syndrome 3,
Carney-Stratakis syndrome, Hereditary cancer-predisposing syndrome
Likely benign
(Mar 4, 2020)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr11:111957671
GRCh38:
Chr11:112086947
LOC126861339, SDHDHereditary cancer-predisposing syndrome, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3, Pheochromocytoma
Likely benign
(Jul 24, 2022)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr11:111957673
GRCh38:
Chr11:112086949
LOC126861339, SDHDCowden syndrome 3, Pheochromocytoma, Paragangliomas with sensorineural hearing loss,
Carney-Stratakis syndrome, Hereditary cancer-predisposing syndrome
Likely benign
(Apr 26, 2020)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr11:111957674-111957706
GRCh38:
Chr11:112086950-112086982
LOC126861339, SDHDPheochromocytoma, Carney-Stratakis syndrome, Cowden syndrome 3,
Paragangliomas with sensorineural hearing loss
Likely pathogenic
(Jul 18, 2019)
criteria provided, single submitter
68.
GRCh37:
Chr11:111957674
GRCh38:
Chr11:112086950
LOC126861339, SDHDG15RCowden syndrome 3, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Pheochromocytoma
Uncertain significance
(Aug 23, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr11:111957675
GRCh38:
Chr11:112086951
LOC126861339, SDHDG15AHereditary cancer-predisposing syndrome, Pheochromocytoma, Carney-Stratakis syndrome,
Cowden syndrome 3, Paragangliomas with sensorineural hearing loss
Uncertain significance
(Aug 29, 2022)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr11:111957676
GRCh38:
Chr11:112086952
LOC126861339, SDHDPheochromocytoma, Carney-Stratakis syndrome, Cowden syndrome 3,
Paragangliomas with sensorineural hearing loss
Likely benign
(Apr 16, 2021)
criteria provided, single submitter
71.
GRCh37:
Chr11:111957677
GRCh38:
Chr11:112086953
LOC126861339, SDHDG16CCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Pheochromocytoma,
Cowden syndrome 3, not provided
Uncertain significance
(Dec 17, 2021)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr11:111957677
GRCh38:
Chr11:112086953
LOC126861339, SDHDG16RCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Pheochromocytoma,
Cowden syndrome 3
Uncertain significance
(Aug 26, 2021)
criteria provided, single submitter
73.
GRCh37:
Chr11:111957679
GRCh38:
Chr11:112086955
LOC126861339, SDHDPheochromocytoma, Cowden syndrome 3, Carney-Stratakis syndrome,
Paragangliomas with sensorineural hearing loss, Hereditary cancer-predisposing syndrome
Likely benign
(Jul 7, 2021)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr11:111957680
GRCh38:
Chr11:112086956
LOC126861339, SDHDR17*Pheochromocytoma, Carney-Stratakis syndrome, Cowden syndrome 3,
Paragangliomas with sensorineural hearing loss, Hereditary cancer-predisposing syndrome, not provided
Pathogenic
(Jan 27, 2023)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr11:111957680
GRCh38:
Chr11:112086956
LOC126861339, SDHDR17Gnot specified, not provided, Hereditary cancer-predisposing syndrome,
Pheochromocytoma, Carney-Stratakis syndrome, Cowden syndrome 3,
Paragangliomas with sensorineural hearing loss
Uncertain significance
(Aug 23, 2022)
criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr11:111957681
GRCh38:
Chr11:112086957
LOC126861339, SDHDR17QPheochromocytoma, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3
Uncertain significance
(Aug 28, 2021)
criteria provided, single submitter
77.
GRCh37:
Chr11:111957682
GRCh38:
Chr11:112086958
LOC126861339, SDHDHereditary cancer-predisposing syndromeUncertain significance
(Jun 16, 2020)
criteria provided, single submitter
78.
GRCh37:
Chr11:111957682
GRCh38:
Chr11:112086958
LOC126861339, SDHDCowden syndrome 3, Pheochromocytoma, Paragangliomas with sensorineural hearing loss,
Carney-Stratakis syndrome
Uncertain significance
(Jul 18, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr11:111957684-111957685
GRCh38:
Chr11:112086960-112086961
LOC126861339, SDHDPheochromocytoma, Carney-Stratakis syndrome, Cowden syndrome 3,
Paragangliomas with sensorineural hearing loss, Hereditary cancer-predisposing syndrome
Pathogenic/Likely pathogenic
(Apr 11, 2023)
criteria provided, multiple submitters, no conflicts
80.
GRCh37:
Chr11:111957684
GRCh38:
Chr11:112086960
LOC126861339, SDHDParagangliomas with sensorineural hearing loss, Cowden syndrome 3, Pheochromocytoma,
Carney-Stratakis syndrome, Hereditary cancer-predisposing syndrome
Pathogenic
(Dec 20, 2021)
criteria provided, multiple submitters, no conflicts
81.
GRCh37:
Chr11:111957685
GRCh38:
Chr11:112086961
LOC126861339, SDHDCarney-Stratakis syndrome, Pheochromocytoma, Paragangliomas with sensorineural hearing loss,
Cowden syndrome 3
Pathogenic
(Aug 28, 2021)
criteria provided, single submitter
82.
GRCh37:
Chr11:111957685
GRCh38:
Chr11:112086961
LOC126861339, SDHDPheochromocytomaLikely pathogenic
(Nov 30, 2021)
criteria provided, single submitter
83.
GRCh37:
Chr11:111957687-111957688
GRCh38:
Chr11:112086963-112086964
LOC126861339, SDHDPheochromocytoma, Carney-Stratakis syndrome, Cowden syndrome 3,
Paragangliomas with sensorineural hearing loss
Likely benign
(Aug 5, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr11:111957688
GRCh38:
Chr11:112086964
LOC126861339, SDHDPheochromocytoma, Cowden syndrome 3, Paragangliomas with sensorineural hearing loss,
Carney-Stratakis syndrome
Benign
(Feb 12, 2021)
criteria provided, single submitter
85.
GRCh37:
Chr11:111957688
GRCh38:
Chr11:112086964
LOC126861339, SDHDPheochromocytoma, Cowden syndrome 3, Carney-Stratakis syndrome,
Paragangliomas with sensorineural hearing loss, Hereditary cancer-predisposing syndrome
Uncertain significance
(Apr 11, 2023)
criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr11:111957688
GRCh38:
Chr11:112086964
LOC126861339, SDHDCowden syndrome 3, Carney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss,
Pheochromocytoma, Hereditary cancer-predisposing syndrome
Uncertain significance
(Mar 29, 2020)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr11:111957689
GRCh38:
Chr11:112086965
LOC126861339, SDHDCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Pheochromocytoma,
Cowden syndrome 3
Uncertain significance
(May 27, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr11:111957690
GRCh38:
Chr11:112086966
LOC126861339, SDHDParagangliomas with sensorineural hearing loss, Carney-Stratakis syndrome, Pheochromocytoma,
Cowden syndrome 3
Likely benign
(Mar 15, 2021)
criteria provided, single submitter
89.
GRCh37:
Chr11:111957691
GRCh38:
Chr11:112086967
LOC126861339, SDHDPheochromocytoma, Carney-Stratakis syndrome, Cowden syndrome 3,
Paragangliomas with sensorineural hearing loss
Likely benign
(May 19, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr11:111957693
GRCh38:
Chr11:112086969
LOC126861339, SDHDPheochromocytoma, Cowden syndrome 3, Paragangliomas with sensorineural hearing loss,
Carney-Stratakis syndrome
Likely benign
(Jul 19, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr11:111957695
GRCh38:
Chr11:112086971
LOC126861339, SDHDCowden syndrome 3, Carney-Stratakis syndrome, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Likely benign
(Sep 1, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr11:111957696
GRCh38:
Chr11:112086972
LOC126861339, SDHDPheochromocytoma, Cowden syndrome 3, Paragangliomas with sensorineural hearing loss,
Carney-Stratakis syndrome
Likely benign
(Nov 1, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr11:111957698
GRCh38:
Chr11:112086974
LOC126861339, SDHDPheochromocytoma, Cowden syndrome 3, Paragangliomas with sensorineural hearing loss,
Carney-Stratakis syndrome
Likely benign
(Aug 8, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr11:111957700
GRCh38:
Chr11:112086976
LOC126861339, SDHDPheochromocytoma, Cowden syndrome 3, Paragangliomas with sensorineural hearing loss,
Carney-Stratakis syndrome
Likely benign
(Oct 15, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr11:111957701
GRCh38:
Chr11:112086977
LOC126861339, SDHDParagangliomas with sensorineural hearing loss, Pheochromocytoma, Carney-Stratakis syndrome,
Cowden syndrome 3
Likely benign
(May 27, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr11:111957702
GRCh38:
Chr11:112086978
LOC126861339, SDHDCarney-Stratakis syndrome, Cowden syndrome 3, Pheochromocytoma,
Paragangliomas with sensorineural hearing loss
Likely benign
(Dec 17, 2021)
criteria provided, single submitter
97.
GRCh37:
Chr11:111957707
GRCh38:
Chr11:112086983
LOC126861339, SDHDHereditary cancer-predisposing syndromeLikely benign
(Dec 1, 2015)
no assertion criteria provided
98.
GRCh37:
Chr11:111957819
GRCh38:
Chr11:112087095
LOC126861339, SDHDnot providedBenign
(Jun 23, 2018)
criteria provided, single submitter
99.
GRCh37:
Chr11:111958526-111958529
GRCh38:
Chr11:112087802-112087805
SDHDCarney-Stratakis syndrome, Paragangliomas with sensorineural hearing loss, Cowden syndrome 3,
Pheochromocytoma, Hereditary cancer-predisposing syndrome, not specified
Benign/Likely benign
(Oct 29, 2022)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr11:111958563
GRCh38:
Chr11:112087839
SDHDParagangliomas with sensorineural hearing loss, Pheochromocytoma, Cowden syndrome 3,
Carney-Stratakis syndrome
Likely benign
(Oct 8, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination